MERS
The Middle East respiratory syndrome (MERS), was first reported in Saudi Arabia in 2012. The respiratory illness is caused by a coronavirus, a distant viral cousin to SARS. It spread to 27 countries in Europe, Africa, Asia, and North America. Like many coronaviruses, MERS is a zoonotic virus, which means it is transmitted between animals and humans. According to scientists, MERS most likely passed from bats into dromedary camels before jumping to humans. Since 2012, such as in (figure 3) represented by the chart there have been 2,494 reported cases of MERS and 858 deaths from the virus. Infections occurred primarily from close human-to-human contact, according to the (WHO). The incubation period (the time between infection and start of symptoms) is about five days, but it can occasionally be up range from two to 14 days. There have been no cases of SARS for over a decade. But MERS is an ongoing public health concern.
MERS-CoV risk factor: the risk of severe infection for MERS-CoV is the elderly people and those suffering from the second diseases like heart disease, type one and type two of diabetes and other persons under the medical conditions like liver disease any person with this characteristics are at the risk of severe infection with MERS-CoV and the other persons under the major risk factors like caregivers, nurses and household contacts, and directly contact with camel body fluids that exposed to the virus(Alraddadi, Watson et al. 2016).
MERS symptoms and signs : the symptoms begin with fever and mild cough, and it often made problem in the lungs via severe shortness of breath and it made disability maintain oxygenation. Those peoples with severely affected with a fatal type of respiratory failure like adult respiratory distress syndrome (ARDS). Despite affecting the alveoli of the lungs also attacking other organs of the body such as kidneys and heart and become a problem for blood clotting and those people suffering from autoimmune diseases such as severe rheumatoid arthritis(Mailles, Blanckaert, et al. 2013).
treatment for MERS-CoV: Because MERS-CoV is caused by a similar virus like SARS, the management of MERS-CoV has been extrapolated from experience with the 2002 SARS outbreak and some limited experimental data. Like SARS, patients with MERS-CoV often require oxygen supplementation, and severe cases require mechanical ventilation and intensive-care-unit support. No medication has been proven to treat MERS-CoV, and treatment is based upon the patient’s medical condition. Several medications have been tried in both SARS and MERS-CoV without conclusive benefits, and further research is to be done. Management of the individual with MERS is aided by infectious disease, pulmonary, and critical-care specialists. The common antiviral drugs used at the time of infectious, against the SARS-COVID1 were like the most effective medicine. (Greenberg 2016)
vaccine for MERS-CoVNo vaccine is commercially available at the time of writing.